Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Revenue

Pharmosa Biopharm had revenue of 1.79M TWD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 69.06M, down -58.77% year-over-year. In the year 2025, Pharmosa Biopharm had annual revenue of 67.27M, down -59.86%.

• Revenue (ttm): 69.06M
• Revenue Growth: -58.77%
• P/S Ratio: 67.89
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.27M	-100.30M	-59.86%
Dec 31, 2024	167.57M	-146.93M	-46.72%
Dec 31, 2023	314.50M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error